Adenovirus type 5 (Ad5) has been intensively studied as a viral vector for gene therapy, and understanding host–Ad5 interactions will be key to the safe and effective use of this vector. A recent study in mice provides new insights in this area by showing that Ad5 enlists a host coagulation factor to overcome complement-mediated blockade and infect the liver (pages 452–457).
References
Raper, S.E. et al. Mol. Genet. Metab. 80, 148–158 (2003).
Xu, Z. et al. Nat. Med. 19, 452–457 (2013).
Wickham, T.J. et al. Cell 73, 309–319 (1993).
Kalyuzhniy, O. et al. Proc. Natl. Acad. Sci. USA 105, 5483–5488 (2008).
Waddington, S.N. et al. Cell 132, 397–409 (2008).
Shayakhmetov, D.M. et al. J. Virol. 79, 7478–7491 (2005).
Smith, T.A. et al. Hum. Gene Ther. 14, 777–787 (2003).
Cooper, N.R. & Nemerow, G.R. Springer Semin. Immunopathol. 6, 327–347 (1983).
Xu, Z. et al. J. Virol. 82, 11705–11713 (2008).
Khare, R. et al. J. Virol. 86, 2293–2301 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Nemerow, G. Coagulation factor defends adenovirus from immune attack. Nat Med 19, 406–407 (2013). https://doi.org/10.1038/nm.3149
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.3149
- Springer Nature America, Inc.